This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: The Innovative Contributions of Constanze Banz
Introduction
Constanze Banz is a notable inventor based in Luebeck, Germany. She has made significant strides in the field of medical research, particularly in the treatment of insulin deficiency and diabetes. Her work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Constanze Banz holds a patent for the "Use of Bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes." This invention focuses on the application of Bridge-1 polynucleotides and polypeptides, along with their activators and inhibitors, to address Bridge-1 mediated disorders, including diabetes. This patent highlights her innovative approach to tackling complex medical issues.
Career Highlights
Banz is associated with The General Hospital Corporation, where she continues to contribute to groundbreaking research. Her dedication to advancing medical science is evident in her work and the impact it has on the healthcare community.
Collaborations
Throughout her career, Constanze has collaborated with esteemed colleagues such as Joel F. Habener and Melissa K. Thomas. These partnerships have fostered an environment of innovation and have led to significant advancements in their shared field of research.
Conclusion
Constanze Banz's contributions to the field of diabetes treatment through her innovative patent demonstrate her commitment to improving healthcare. Her work, along with her collaborations, continues to pave the way for future advancements in medical science.